Study of Escitalopram in Adult Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00108979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-Blind Study of Escitalopram in Adult Patients With Major Depressive Disorder
Study identification
- NCT ID
- NCT00108979
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- Escitalopram Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2005
- Primary completion
- Jun 30, 2006
- Completion
- Jun 30, 2006
- Last update posted
- Mar 4, 2012
2005 – 2006
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Health, Ltd. | Phoenix | Arizona | 85016 | — |
| Summit Research Network | Okemos | Michigan | 48864 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| CNS Research Institute | Philadelphia | Pennsylvania | 19149 | — |
| Clinical Neuroscience Solutions | Memphis | Tennessee | 38119 | — |
| Radiant Research | Salt Lake City | Utah | 84107 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98004 | — |
| Summit Research Network | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00108979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2012 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00108979 live on ClinicalTrials.gov.